These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli. Chatterjee SS; Karmacharya R; Madhup SK; Gautam V; Das A; Ray P Indian J Med Microbiol; 2010; 28(3):267-8. PubMed ID: 20644325 [No Abstract] [Full Text] [Related]
9. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Carmeli Y; Akova M; Cornaglia G; Daikos GL; Garau J; Harbarth S; Rossolini GM; Souli M; Giamarellou H Clin Microbiol Infect; 2010 Feb; 16(2):102-11. PubMed ID: 20085604 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond. Boyle DP; Zembower TR Urol Clin North Am; 2015 Nov; 42(4):493-505. PubMed ID: 26475946 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of MRSA and Gram-negative bacteria with ESBLs and carbapenemases in patients from Northern Africa at a German hospital. Leistner R; Denkel LA; Gastmeier P; Werner G; Layer F; Pfeifer Y J Antimicrob Chemother; 2015 Nov; 70(11):3161-4. PubMed ID: 26216582 [No Abstract] [Full Text] [Related]
12. The current state of multidrug-resistant gram-negative bacilli in North America. Nicasio AM; Kuti JL; Nicolau DP Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969 [TBL] [Abstract][Full Text] [Related]
13. Bacterial resistance, beta-lactam antibiotics and gramnegative bacteria at ICUs. Reisinger EC; Allerberger F Wien Klin Wochenschr; 1999 Jul; 111(14):537-8. PubMed ID: 10467639 [No Abstract] [Full Text] [Related]
14. [Beta-lactamase production and the patterns of bacterial resistance, 1988-1991]. Rodríguez Noriega E; Morfín Otero R; Esparza Ahumada S Gac Med Mex; 1994; 130(5):355-60. PubMed ID: 7607365 [TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs). Giamarellou H Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():1-16. PubMed ID: 15953019 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of extended-spectrum beta-lactamases in South America. Villegas MV; Kattan JN; Quinteros MG; Casellas JM Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():154-8. PubMed ID: 18154539 [TBL] [Abstract][Full Text] [Related]
17. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli. Lee K; Kim CK; Yong D; Jeong SH; Yum JH; Seo YH; Docquier JD; Chong Y J Microbiol Methods; 2010 Nov; 83(2):149-52. PubMed ID: 20801167 [TBL] [Abstract][Full Text] [Related]
18. Influence of disk preparation on detection of metallo-beta-lactamase-producing isolates by the combined disk assay. Andrade SS; Picão RC; Campana EH; Nicoletti AG; Pignatari AC; Gales AC J Clin Microbiol; 2007 Jun; 45(6):2058-60. PubMed ID: 17409202 [TBL] [Abstract][Full Text] [Related]
19. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Akova M; Daikos GL; Tzouvelekis L; Carmeli Y Clin Microbiol Infect; 2012 May; 18(5):439-48. PubMed ID: 22507111 [TBL] [Abstract][Full Text] [Related]
20. Status report on carbapenemases: challenges and prospects. Patel G; Bonomo RA Expert Rev Anti Infect Ther; 2011 May; 9(5):555-70. PubMed ID: 21609267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]